Learning Objective 1: The learner will be able to know the importance of early screening and detection of depression in patients with stroke.
Learning Objective 2: The learner will be able to use the PHQ-9 for early screening and detection of depression in patients with stroke in various settings.
Methods: Study 1: Depression was measured in stroke patients (n=55), able to communicate using the PHQ-9. The inter-rater reliability, test-retest reliability, internal consistency, concurrent validity, diagnostic accuracy and clinical utility were evaluated. Study 2: Depression was measured in patients (n=171) in week 6-8 after stroke using the PHQ-2 and PHQ-9 and diagnosed with the Composite International Diagnostic Interview (CIDI).
Results: Study 1: The inter-rater reliability (ICC = 0.98), the test-retest reliability (ρSp = 0.75, p<0.001) and the internal consistency (Cronbach’s α = 0.79) of the PHQ-9 were good. The concurrent validity was moderate for the PHQ-9, and acceptable for the PHQ-2. The optimum cut-off point of the PHQ-9 for major depression was 10 (sensitivity, 100%; specificity, 86%; positive predicted value, 50%; negative predicted value, 100%). For the PHQ-2 it was 2 (sensitivity, 100%; specificity, 77%; positive predicted value, 38% and negative predicted value, 100%). Study 2: The PHQ-9 performed best at a score ≥10 (sensitivity: 0,80, specificity: 0.79) and the PHQ-2 at a score ≥2 (sensitivity: 0.75, specificity: 0.76). Administering the PHQ-9 only to patients who scored ≥2 on the PHQ-2 improved the identification of depression.
Conclusion: The PHQ is a brief and easy-to-use instrument showing good clinimetric properties for patients with stroke able to communicate. The diagnostic value for scores of ≥10 (PHQ-9) and ≥2 PHQ-2, but conducting a PHQ-9 only in patients with a PHQ-2 score ≥ 2 generates the best results. Based on these findings the PHQ can be recommended for nurses to use for the early detection of depression in patients with stroke.
See more of: Research Sessions: Oral Paper & Posters